Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.85 | N/A |
| PEG Ratio (TTM) | 2.05 | N/A |
| P/S Ratio (TTM) | 0.74 | N/A |
| P/B Ratio (TTM) | 3.21 | N/A |
| P/FCF Ratio (TTM) | 14.05 | N/A |
| Price to 5YR AVG Earnings Ratio | 51.66 | N/A |
| Price to 5YR AVG FCF Ratio | 26.16 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.29% | N/A |
| ROE (TTM) | 16.88% | N/A |
| Net Profit Margin (TTM) | 3.75% | N/A |
| ROIC 5YR AVG | 7.76% | N/A |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.34% | -7.20% | 46.62% |
| Revenue | 3.15% | -1.89% | 8.13% |
| Net Income | 10.87% | -7.61% | 42.40% |
| Cash Flow | 4.33% | 36.79% | 345.69% |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.24 | N/A |
| Quick Ratio (TTM) | 1.80 | N/A |
| D/E Ratio (TTM) | 1.34 | N/A |
| Interest Coverage (TTM) | 2.17 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.44 | N/A |
| LTL to 5YR AVG FCF | 11.27 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.65% | N/A |